Sun Pharma introduces Ilumya in India for treatment of plaque psoriasis
Ilumya is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials
Ilumya is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
PRX-PLUS has a unique product feature with its deep-impacting formula
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Glenmark released Picture Post Cards on World Vitiligo Day
Cureskin aims to disrupt the large and growing skin and hair care industry in India
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
WINLEVI works differently from any other topical acne treatment
Subscribe To Our Newsletter & Stay Updated